Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Citibank, C, uitverkoop +toch veilig
Volgen
Howdy, Vorig jaar nog $55, nu $6.50, en 2 van de wereld's rijkste mannen kopen aandelen, Arabische prins en Mexicaans miljardair, plus nog eens Uncle Sam, die glimlachend toekijkt. Wat wil je nog meer ? C, Nyse Succes >--:-)--> p.s. +Paul Volcker aan het roer in Obama's economie
dus je hebt op 3,77 gekocht?
ik heb ze net juist weer weggedaan met een leuke winst, maar zou nog best wel verder kunnen klimmen. Maar wilde per se wat geld vrijmaken. Heb geen haast, er komen nog veel kansen.
heb ze gekocht op 3,91 en 6,49 en houd ze vast tot dat we op 25 dollar staan over 6 maanden
maurice43 schreef:
heb ze gekocht op 3,91 en 6,49 en houd ze vast tot dat we op 25 dollar staan over 6 maanden
Als je bereid bent om er wat langer in te zitten zou ik eerder Morgan Stanley aanraden, als je kijkt naar balans en winstcijfers dan is die relatief veel goedkoper dan Citi.
gewone aandelen van financials zou ik geen aanrader noemen. prefs wel interessant (alhoewel een stuk minder dan vorige week).
Ja, PGF (tracker op preferred financials) op 9.70 vorige vrijdag was interessant. Zat ik op te loeren, maar zat toen net in Belgie. Later wel gekocht voor 10.90. Ook wel tevreden mee
arjan k schreef:
dus je hebt op 3,77 gekocht?
Howdy, Gekocht op 3.77? Nee, mijn naam is niet Warren Buffett. Gekocht 5.89, 6.20, en 6.31 Verkocht zelfde dag 7.03 en 7.25 Die ik nog heb blijf ik nu houden. Mocht er 'n dip komen, dan koop ik weer voor KT trade. Houdoe >--:-)-->
Amor Arrows schreef:
Howdy,
Vorig jaar nog $55, nu $6.50, en 2 van de wereld's rijkste mannen kopen aandelen, Arabische prins en Mexicaans miljardair, plus nog eens Uncle Sam, die glimlachend toekijkt.
Wat wil je nog meer ?
C, Nyse
Succes
>--:-)-->
p.s. +Paul Volcker aan het roer in Obama's economie
Follow-up: btw vrijdag close @ $8.29 en most active stock on the NYSE TheStreet.com Citi Gets Bullish Nod From Former Bear Friday November 21, 1:13 pm ET ByMarek Fuchs, Special to TheStreet.com It is The Business Press Maven's manifest destiny to make fun of Wall Street analyst doublespeak and of how the business media, in need of quotes, take the chuckleheads seriously. But what happens when an analyst puts his reputation on the line and makes a gutsy bullish call on a troubled company during a profoundly bad day? And what if that analyst was, a year ago, one of the biggest bears around on the same company? You'd figure it would at least be mentioned in the business media's coverage. Or maybe not. Yesterday, Ladenburg Thalmann's Dick Cove came out in support of Citigroup, an interesting enough call on its own, made even more interesting by his bearish history on the stock. Reuters did cover Bove's bullish call yesterday, but it made no mention of the fact that a year ago, while other analysts and investors were misguidedly singing Citi's praises, Bove was courageously bearish. This article from the Associated Press about Citigroup's miserable day yesterday, during which the stock plunged below $5, didn't mention Bove at all, even though he's more interesting -- and qualified -- than the analysts who do show up in the piece. Yesterday Bove did something few analysts ever do: He took a counterintuitive stand. He said there was no reason Citigroup should fail. He spoke about its sufficient cash flow, its ability to roll over its liabilities, its positive net interest income and how it would take a depression "every bit as large and long as the 1930s debacle to shake this company's viability." Added Bove: "The current decline in the stock price is reflecting a series of fears. ... I would be a buyer of the stock." Amid wretchedness and panic (as during splendidness and elation), counterintuitive stands are what make you money, but Bove's stand is notable also for what preceded it, when Bove was often Citigoup's lone skeptic. In an October 2007 L.A. Times piece, he rightly spoke out against Citi's it's-our-last-write-off canard: "One skeptic was analyst Richard Bove of Punk, Ziegel & Co., who had downgraded Citigroup in July. Bove contended that the evaporation of the markets for securities carved out of sub-prime mortgages and takeover loans -- areas of huge growth for big banks this decade - would continue to depress the banks' earnings. "Bove compared Prince to former Citi CEO John S. Reed, who in 1987 added a then-staggering $3 billion to the bank's reserves against losses in developing nations and declared the problem solved. Reed called it `the write-offs to end all write-offs,' Bove recalled. "But in 1991, Reed, forced to set aside additional funds for losses in Latin America, eliminated the bank's dividend, Bove said. "Like Reed, Prince may have an imperfect vision of the future, Bove said. `It's not just a write-off we're talking about here; it's a change in the structure of the market.'" Earlier in 2007, Citigroup had staged an April massacre, announcing a cut of 17,000, and many had applauded. But Bove stuck to his bearish guns: "'There's nothing new in anything new that was said in this meeting today,' said Dick Bove, an analyst with Punk, Ziegel & Co. `Citigroup has already been delayering management and optimizing technology under CEO Charles Prince. It's merely a continuation of existing programs, which in my view is not good.'" Bove was an outspoken critic of Citigroup for more than just its financial circumstances. In a May 2007 New York Times story called "Citigroup Works Both Sides of Distiller Deal," Bove took the company to task for a potential conflict of interest, something Wall Street analysts, traditionally no strangers to conflict of interest, rarely do: "Still, some outsiders were surprised by Citigroup's dual role. `I think it's unusual and the potential for conflict is extremely high,' said Richard X. Bove, analyst with Punk, Ziegel, an independent research firm. `How does the seller know he's getting the best price possible, and how does the buyer know he's getting the best financing deal possible?' "Citigroup could face problems down the road if, for example, the whiskey company's assets have not been accurately represented, Mr. Bove said, leaving Citigroup open for lawsuits. United Spirits is a publicly traded company." This is not to say that Bove will be right with yesterday's contrarian bullish report or that all his past calls were perfect. But considering his contrarian bearish past on the same company, the savvy investor should take note. And the business media, who give plenty of undue credit to analysts, should give some where it's actually due. >--:-)-->
Bove is een windvaan. Lees het volgende artikeltje maar eens goed: www.marketwatch.com/news/story/citigr... DB praat alleen maar over assets en niet over liabilities... Tralala, pomtiedomtiedom... Weer een "analyst" naar de schroothoop en dan ook nog met het "excuus" dat "not all calls in the past were perfect". D.B. heeft het in het verleden dus wel eens eerder ernstig fout gehad... Kortom: dat kan u nu weer gebeuren. Garantie tot de voordeur, yadayadayada... E.
Citibank van 56 naar 1 dollar in 14 maanden. Dit moet voor veel mensen en instellingen een onvoorstelbaar drama zijn.
Niet alleen dat maar die tientallen miljarden die ze moeten binnenhalen gaat ze niet lukken, ook BoA en AIG gaat dit niet lukken Maar gelukkig mogen wij ons verdedigenwww.nu.nl/algemeen/1927949/europa-hee... Waar bemoeien ze zich toch mee, continu verdraaien van feiten is gewoon daar Leuke poging AA
maurice43 schreef:
heb ze gekocht op 3,91 en 6,49 en houd ze vast tot dat we op 25 dollar staan over 6 maanden
nog 3 maanden, om van 1 naar 25 te stijgen maurice
AIG en Citibank failiet laten gaan. Het leed is al geleden, de aandelen zijn nagenoeg niets meer waard. Straffen voor wanbeleid. Bedrijven als AIG voortaan taboe. Obligatieverzekeraar. Wat een kolder. Zo wordt de economie gezuiverd. De belastingbetaler hoeft geen geld meer te stoppen in deze bodemloze putten.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
915,21
+0,10%
EUR/USD
1,0848
0,00%
FTSE 100
8.317,59
-0,26%
Germany40^
18.697,70
+0,03%
Gold spot
2.334,00
0,00%
NY-Nasdaq Composite
16.920,79
+1,10%
Stijgers
Dalers